Our Team

INVESTMENT PROFESSIONAL

Partner and Board Director

ATSUSHI USAMI

  • PROFILE
  • CAREER
  • MEDIA/PUBLICATION
● Focuses on seed/early-stage life science investments

● Led investments including Oriciro Genomics, Inc. (acquired by Moderna, Inc.)
and Repertoire Genesis Inc. (acquired by Eurofins Scientific SE)

● Currently serves on the boards of bitBiome, Bugworks Research,
SOLA Biosciences, RegCell, EditForce, Celaid Therapeutics, United Immunity and others

● Also supports initiatives such as the Life Science Innovation Network Japan (LINK-J)

● Before joining UTEC, he worked as a strategy consultant at Mitsubishi
Research Institute (MRI), serving pharmaceutical, medical device and other manufacturing companies across a range of areas including mid-to-long term management planning and new business development

● In recognition of his contributions, he was awarded the Encouragement Award for Venture Capitalists at the 23rd Japan Venture Awards in 2023
Atsushi Usami studied pharmacology and neuroscience.
He received a Ph.D. in pharmaceutical sciences from the University of Tokyo and is a pharmacist.
He worked as a consultant at MRI before joining UTEC in October 2013.

ATSUSHI USAMI’S
PORTFOLIO